Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse

Experimental Neurology

Volumn 173, Issue 2, 2002, Pages 183-195

  Gordon, Marcia N ^a   Holcomb, Leigh A ^a   Jantzen, Paul T ^a   DiCarlo, Giovanni ^a   Wilcock, Donna ^a   Boyett, Kristal W ^a   Connor, Karen ^a   Melachrino, Jason ^a   O'Callaghan, James P ^b   Morgan, Dave ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COMPLEMENT RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEADY STATE; TRANSGENIC MOUSE;

EID: 0036175608     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7754     Document Type: Article

References (45)

1. Inflammation and Alzheimer's disease
2. Progressive behavioral impairments in transgenic mice carrying both mutant APP and PS1 transgenes
3. Functional phenotype in transgenic mice expressing mutant human presenilin-1
4. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease
5. Evidence for glial-mediated inflammation in APPsw transgenic mice
6. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor protein
7. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo
8. The pathogenesis of senile plaques
9. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
10. Microglial response to amyloid plaques in APPsw transgenic mice
11. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
12. Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: An immunohistochemical study
13. Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice
14. Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat
15. Age-related changes in glial fibrillary acidic protein RNA in the mouse brain
16. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
17. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits
18. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
19. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
20. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
21. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
22. Modification of microglial reactivity in mAPP/mPS1 transgenic mice using NCX-2216
23. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease
24. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: A regional quantitative analysis
25. Inflammation, Abeta deposition and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration
26. The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy
27. The pathogenesis and progression of the pathological changes of Alzheimer's disease
28. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
29. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
30. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
31. Aging and molecular biology
32. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain
33. High-level neuronal expression of Abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
34. Quantification of glial fibrillary acidic protein: Comparison of slot-immunobinding assays with a novel sandwich ELISA
35. Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity
36. The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain
37. Elevated Aβ levels in Alzheimer's disease brain are associated with a selective accumulation of Aβ42 in parenchymal amyloid deposits, and both Aβ40 and Aβ42 in cerebrovascular deposits
38. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
39. Measurement of protein using bicinchoninic acid
40. Association of microglia with amyloid plaques in brains of APP23 transgenic mice
41. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease
42. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
43. Targeting Alzheimer amyloid plaques in vivo
44. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease